Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The changing economics of DNA synthesis

How are the economics of synthetic biology likely to develop in the coming years?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2


  1. Gibson, D.G. et al. Science 319, 1215–1220 (2008).

    Article  CAS  Google Scholar 

  2. Shao, Z. & Zhao, H. Nucleic Acids Res. 37, e16 (2009).

    Article  Google Scholar 

  3. Borokov, A. SynBuild, an accurate high-throughput gene assembly platform that uses microarray synthesized oligos. Poster at Synthetic Biology 4.0, Hong Kong, China, October 10–12, 2008.

  4. Gibson, D.G. Nucleic Acids Res. published online, 10.1093/nar/gkp687 (10 September 2009).

  5. Keasling, J.D. Synthetic biology in pursuit of low-cost, effective, anti-malarial drugs. Presentation at the Institute for Systems Biology Seventh Annual International Symposium, Seattle, April 21, 2008.

  6. Carlson, R. Nat. Biotechnol. 27, 984 (2009).

    Article  CAS  Google Scholar 

  7. Carlson, R. Syst. Synth. Biol. 1, 109–117 (2007).

    Article  Google Scholar 

  8. Carlson, R. Biology is Technology (Harvard University Press, Cambridge, in the press).

  9. Newcomb, J., Carlson, R. & Aldrich, S. Genome Synthesis and Design Futures: Implications for the US Economy (Bio Economic Research Associates, Cambridge, Massachusetts, 2007).

    Google Scholar 

  10. Garfinkel, M.S., Endy, D., Epstein, G.L. & Friedman, R.M. Synthetic Genomics: Options for Governance (J. Craig Venter Institute, The Center for Strategic and International Studies, Massachusetts Institute of Technology, October 2007).

    Google Scholar 

  11. Carlson, R. Biosecur. Bioterror. 1, 203–214 (2003).

    Article  Google Scholar 

  12. Khorana, H.G. Science 203, 614–625 (1979).

    Article  CAS  Google Scholar 

  13. Mandecki, W., Hayden, M.A., Shallcross, M.A. & Stotland, E. Gene 94, 103–107 (1990).

    Article  CAS  Google Scholar 

  14. Stemmer, W.P.C., Crameria, A., Hab, K.D., Brennan, T.M. & Heynekerb, H.L. Gene 164, 49–53 (1995).

    Article  CAS  Google Scholar 

  15. Cello, J., Paul, A.V. & Wimmer, E. Science 297, 1016–1018 (2002).

    Article  CAS  Google Scholar 

  16. Tian, J. et al. Nature 432, 1050–1054 (2004).

    Article  CAS  Google Scholar 

  17. Kodumal, S.J. et al. Proc. Natl. Acad. Sci. USA 101, 15573–15578 (2004).

    Article  CAS  Google Scholar 

Download references


Portions of this text are drawn from Biology is Technology, scheduled for publication in 2010. I would like to thank J. Mulligan, J. Minshull, J. Koschwanez, L. Stewart, D. Endy and R. Wehbring for illuminating and entertaining discussions.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Robert Carlson.

Ethics declarations

Competing interests

Novici, one of the companies mentioned in this article, is a client of R.C.’s company Biodesic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, R. The changing economics of DNA synthesis. Nat Biotechnol 27, 1091–1094 (2009).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing